Clinical benefits and risks of anticoagulation therapy according to the degree of chronic kidney disease in patients with atrial fibrillation

BACKGROUND: The clinical benefits and risks of anticoagulation therapy in patients with chronic kidney disease (CKD) are still inconclusive. We describe the outcomes of patients with atrial fibrillation (AF) after anticoagulation therapy according to differences in creatinine clearance (CrCl). We al...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Min Soo, Choi, Hyung Oh, Hwang, Ki Won, Kim, Jun, Nam, Gi-Byoung, Choi, Kee-Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131393/
https://www.ncbi.nlm.nih.gov/pubmed/37098477
http://dx.doi.org/10.1186/s12872-023-03236-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131393/
https://www.ncbi.nlm.nih.gov/pubmed/37098477
http://dx.doi.org/10.1186/s12872-023-03236-5

Ejemplares similares